BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25993471)

  • 1. Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
    Long M; Zhou J; Li D; Zheng L; Xu Z; Zhou S
    PLoS One; 2015; 10(5):e0126714. PubMed ID: 25993471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin-A signaling in the paraventricular nucleus modulates spontaneous firing of glucose-sensitive neurons and promotes food intake via the NPY pathway in rats.
    Wang C; Han X; Guo F; Sun X; Luan X; Xu L
    Biochem Biophys Res Commun; 2018 Oct; 505(1):162-167. PubMed ID: 30243725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
    J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y.
    Shi Z; Cassaglia PA; Pelletier NE; Brooks VL
    J Physiol; 2019 Mar; 597(6):1757-1775. PubMed ID: 30628058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity.
    Wang J; Akabayashi A; Dourmashkin J; Yu HJ; Alexander JT; Chae HJ; Leibowitz SF
    Brain Res; 1998 Aug; 802(1-2):75-88. PubMed ID: 9748512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y suppresses thermogenic and cardiovascular sympathetic nerve activity via Y1 receptors in the paraventricular nucleus and dorsomedial hypothalamus.
    Shi Z; Bonillas AC; Wong J; Padilla SL; Brooks VL
    J Neuroendocrinol; 2021 Aug; 33(8):e13006. PubMed ID: 34235800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.
    Rojas JM; Stafford JM; Saadat S; Printz RL; Beck-Sickinger AG; Niswender KD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1479-88. PubMed ID: 23074243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism.
    Billington CJ; Briggs JE; Harker S; Grace M; Levine AS
    Am J Physiol; 1994 Jun; 266(6 Pt 2):R1765-70. PubMed ID: 8024026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
    Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
    Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
    Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
    Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
    Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
    Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice.
    Fukasaka Y; Nambu H; Tanioka H; Obata A; Tonomura M; Okuno T; Yukioka H
    Neuropeptides; 2018 Aug; 70():55-63. PubMed ID: 29801968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice.
    Nguyen AD; Mitchell NF; Lin S; Macia L; Yulyaningsih E; Baldock PA; Enriquez RF; Zhang L; Shi YC; Zolotukhin S; Herzog H; Sainsbury A
    PLoS One; 2012; 7(6):e40191. PubMed ID: 22768253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in moderate/high fat, high-energy diet-fed mice.
    Zammaretti F; Panzica G; Eva C
    J Physiol; 2007 Sep; 583(Pt 2):445-54. PubMed ID: 17584829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.
    Yokosuka M; Kalra PS; Kalra SP
    Endocrinology; 1999 Oct; 140(10):4494-500. PubMed ID: 10499503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.
    Kalra SP; Kalra PS
    Neuropeptides; 2004 Aug; 38(4):201-11. PubMed ID: 15337372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
    Sahu A; Dube MG; Phelps CP; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.